Astrazeneca Fights To Regain Cancer Market Prominence | Latest News RSS feed

Astrazeneca Fights To Regain Cancer Market Prominence - Latest News


REFILE-AstraZeneca fights to regain cancer market prominence

CHICAGO, June 3 (Reuters) - AstraZeneca Plc, in the headlines for spurning buyout offers from Pfizer Inc, aims to regain prominence ... of cancer doctors. The company is seen as No. 4 in a race to ... read more

Add your link right here

Add your story here to improve SEO, search ranking and drive traffic to your website. Your link will be permanently featured right on this page. To add a link on diferent page, just visit the page you want to show your link and click "Add your link right here". You can use search form below to find the page. read more

AstraZeneca's Lynparza, armed with new FDA nod, aims to regain share from Tesaro's Zejula

Lynparza can now fight back. The AstraZeneca drug—now shared ... in their respective first quarters on the market launch, Moulder said. RELATED: AZ looks to extend PARP lead with solid Lynparza breast ... read more

AstraZeneca, Merck strike deal to advance cancer treatments

The Merck tie-up illustrates the growing prominence ... AstraZeneca's Lynparza (olaparib) for multiple cancer types", the pair said. Lynparza is currently approved for treatment of ovarian cancer but ... read more

Looking for another news?


Drugs giants strike deal to advance cancer treatments (Update)

British pharmaceutical giant AstraZeneca and US peer Merck said Thursday they had agreed a multi-billion-dollar deal to jointly develop ... for treatment of ovarian cancer but it is hoped that this ... read more


AstraZeneca Pledges Sales Boost Even as Strong Dollar Bites

AstraZeneca ... are in cancer products, including those that harness the body’s immune system to fight tumors. Astra is betting on its in-house combination of immune-oncology agents, which would ... read more

AstraZeneca, Merck strike key cancer drugs partnership

The Merck tie-up illustrates the growing prominence ... AstraZeneca's Lynparza (olaparib) for multiple cancer types", the pair said. Lynparza is currently approved for treatment of ovarian cancer but ... read more

Global Prostate Cancer Therapeutics Industry

NEW YORK, Feb. 6, 2019 /PRNewswire/ -- This report analyzes the worldwide markets for Prostate Cancer Therapeutics in US$ Million by the following Segments: Hormone ... read more

3 Promising Cancer Immunotherapies to Watch in 2018

Immunotherapies work by spurring the body's immune system to fight cancer ... in clinical-stage development or on the market. Out of that vast number, I think there are three especially promising ... read more

AstraZeneca fights to regain cancer market prominence

(Corrects typo in headline to read 'AstraZeneca' and not 'AztraZeneca') By Deena Beasley CHICAGO, June 3 (Reuters) - AstraZeneca Plc, in the headlines for spurning buyout offers from Pfizer Inc, aims ... read more

3 Promising Cancer Immunotherapies to Watch in 2018

Immunotherapies work by spurring the body's immune system to fight cancer. The approach has gained such incredible traction in the research community that there are now over 2,000 immunotherapies in ... read more

AstraZeneca fights to regain cancer market prominence

AstraZeneca Plc, in the headlines for spurning buyout offers from Pfizer Inc (NYSE: PFE - news) , aims to regain prominence in oncology with compelling trial results and a splashy exhibit booth at the ... read more



FeedsRSS Created by. Full RSS Feed | Privacy Policy | Contact Us